References
- Brambilla D Luciani P Leroux J . Breakthrough discoveries in drug delivery technologies: the next 30 years. J. Cont. Rel.190, 9–14 (2014).
- Transdermal Market Report . www.micromarketmonitor.com/market-report/transdermal-drug-delivery-systems-reports-8097662643.html.
- McCrudden MT Singh TRR Migalska K Donnelly RF . Strategies for enhanced peptide and protein delivery. Ther. Deliv.4, 593–614 (2013).
- Biotechnology Drugs Market Report . www.bccresearch.com/market-research/biotechnology.
- Douroumis D Fahr A . Drug Delivery Strategies for Poorly Water-Soluble Drugs. Wiley, Oxford, UK (2013).
- Drug Devices . www.drug-dev.com.
- Grand View Research, Inc . www.grandviewresearch.com/industry-analysis/transdermal-drug-delivery-systems-industry.
- Donnelly RF Singh TRR Morrow DIJ Woolfson AD . Microneedle-Mediated Transdermal and Intradermal Drug Delivery. Wiley, Oxford, UK (2012).
- Donnelly RF Singh TRR Garland MJ et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv. Funct. Mater.22, 4879–4890 (2012).
- Kearney MC Caffarel-Salvador E Fallows SJ McCarthy HO Donnelly RF . Microneedle-mediated delivery of donepezil: potential for improved treatment options in Alzheimer's disease. Eur. J. Pharm. Biopharm.103, 43–50 (2016).
- Song Y Herwadkar A Patel MG Banga AK . Transdermal delivery of cimetidine across microneedle-treated skin: effect of extent of drug ionization on the permeation. J. Pharm. Sci. doi:10.1016/j.xphs.2017.01.005 (2017) ( Epub ahead of print).
- McGrath MG Vrdoljak A O'Mahony C Oliveira JC Moore AC Crean AM . Determination of parameters for successful spray coating of silicon microneedle arrays. Int. J. Pharm.415, 140–149 (2011).
- Yang HW Ye L Guo XD Yang C Compans RW Prausnitz MR . Ebola vaccination using a DNA vaccine coated on PLGA-PLL/γPGA nanoparticles administered using a microneedle patch. Adv. Healthc. Mater.6 (1), (2017). doi:10.1002/adhm.201600750.
- Pearton M Pirri D Kang SM Compans RW Birchall JC . Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine. Adv. Healthc. Mater.2, 1401–1410 (2013).
- Fernando GJ Zhang J Ng HI Haigh OL Yukiko SR Kendall MA . Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses. J. Control. Rel.237, 35–41 (2016).
- Janssen Duragesic . www.duragesic.com.
- Novartis Nicotinell . www.nicotinell.co.uk.
- Donnelly RF Moffatt K Alkilani AZ et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm. Res.31, 1989–1999 (2014).
- Norman JJ Arya JM McClain MA Frew PM Meltzer MI Prausnitz MR . Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine32, 1856–1862 (2014).
- Vicente-Pérez EM Quinn HL McAlister E et al. The use of a pressure-indicating sensor film to provide feedback upon hydrogel-forming microneedle array self-application in vivo. Pharm. Res.33, 3072–3080 (2016).
- Ripolin A Quinn J Vicente-Pérez EM Larrañeta E Barry JG Donnelly RF . Successful application of large microneedle patches by human volunteers. Int. J. Pharm. doi: 10.1016/j.ijpharm.2017.02.011 (2017) ( Epub ahead of print).
- Sedita J . Microneedles: cost of goods analysis. Proceedings of Microneedles 2016, London (2016).
- Watkinson AC Kearney MC Quinn HL Courtenay AJ Donnelly RF . Future of the transdermal drug delivery market: have we barely touched the surface?Expert Opin. Drug Deliv.13, 523–532 (2016).
- Lutton REM Moore J Larrañeta E Ligett S Woolfson AD Donnelly RF . Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv. Transl. Res.5, 313–331 (2015).
- Liu S Wu D Quan YS et al. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid. Mol. Pharm.13, 272–279 (2016).
- Birchall JC Clemo R Anstey A John DN . Microneedles in clinical practice: an exploratory study into the opinions of healthcare professionals and the public. Pharm. Res.28, 95–106 (2011).
- Vicente-Pérez EM Larrañeta E McCrudden MTC et al. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo. Eur. J. Phar. Biopharm (2017) ( In Press).